Sagefield Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Sagefield Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,900	Closed	-$718K	–	136
2022 Q3	$718K	Buy	+13,900	New	+$575K	0.23%	77

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sagefield Capital's CCXI Position: Q4 2022 in Review

Sagefield Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 13,900 shares — an estimated $718K sold.

Sagefield Capital first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $718K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Sagefield Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Sagefield Capital sold 13,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $718K.
Sagefield Capital first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Sagefield Capital's ChemoCentryx, Inc. position peaked at $718K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Sagefield Capital's 13F filing for Q4 2022, filed 14 Feb 2023.